Drug treatment, remdesivir – an anti-viral medicine that has been used against Ebola, appears to shorten recovery time for people with coronavirus is being made available on the NHS. Health Secretary Matt Hancock said it was probably the biggest step forward in the treatment of coronavirus since the crisis began. UK regulators say there is
The new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks. The ACCORD-2 collaboration will examine the effectiveness of repurposed medicines, potential new drugs, and currently unlicensed therapies in treating COVID-19 patients. Drug compounds that demonstrate effectiveness and safety in the early clinical trials stage
NHS England says it is scaling up its capacity for testing people for the infection. Meaning 10,000 tests a day can be done – 8,000 more than the 1,500 being carried out currently. Confirmation of any positive test results are then escalated by helping people take the right action to recover or quickly get treatment.
As it is Healthcare Science Week we would like to shout out about our fully funded, award winning Graduate Training Academy for those looking to get their first in industry role within clinical trials. We are extremely proud that it has Science Council employer champion status and has won multiple industry awards for innovation. The
UK government has backed five new centres for AI in health, which will be focusing on areas that includes pathology, radiology and imaging. Centres will be based in Leeds, Oxford, Coventry, Glasgow and London. Utilising £50m in funding, the new centres will bring together doctors, businesses and academics to collaborate on the development of products
Lilly has recently announced their goal to expand global access to healthcare for 30 million people in resource-limited locations by 2030. The scheme, known as Lilly 30×30, is a new five-year, $90 million investment in the Lilly Global Health Partnership, to improve access to treatment for diabetes, cancer and tuberculosis. One half of the $90
Google have dominated the tech news this week as it announced its plans to re-organise the company and sub divisions over the next coming months in order to create a more streamlined and leaner organisation. The technology titan has created an over-arching holding company (Alphabet), which Google and its various other companies will become subsidiaries